Survival in Southern European patients waitlisted for kidney transplant after graft failure: A competing risk analysis

PLoS One. 2018 Mar 7;13(3):e0193091. doi: 10.1371/journal.pone.0193091. eCollection 2018.

Abstract

Background: Whether patients waitlisted for a second transplant after failure of a previous kidney graft have higher mortality than transplant-näive waitlisted patients is uncertain.

Methods: We assessed the relationship between a failed transplant and mortality in 3851 adult KT candidates, listed between 1984-2012, using a competing risk analysis in the total population and in a propensity score-matched cohort. Mortality was also modeled by inverse probability weighting (IPTW) competing risk regression.

Results: At waitlist entry 225 (5.8%) patients had experienced transplant failure. All-cause mortality was higher in the post-graft failure group (16% vs. 11%; P = 0.033). Most deaths occurred within three years after listing. Cardiovascular disease was the leading cause of death (25.3%), followed by infections (19.3%). Multivariate competing risk regression showed that prior transplant failure was associated with a 1.5-fold increased risk of mortality (95% confidence interval [CI], 1.01-2.2). After propensity score matching (1:5), the competing risk regression model revealed a subhazard ratio (SHR) of 1.6 (95% CI, 1.01-2.5). A similar mortality risk was observed after the IPTW analysis (SHR, 1.7; 95% CI, 1.1-2.6).

Conclusions: Previous transplant failure is associated with increased mortality among KT candidates after relisting. This information is important in daily clinical practice when assessing relisted patients for a retransplant.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / mortality
  • Cause of Death
  • Cohort Studies
  • Europe
  • Graft Survival
  • Humans
  • Kidney Transplantation / adverse effects
  • Kidney Transplantation / mortality
  • Kidney Transplantation / statistics & numerical data*
  • Propensity Score
  • Registries / statistics & numerical data*
  • Risk Assessment / methods
  • Risk Assessment / statistics & numerical data*
  • Risk Factors
  • Survival Analysis
  • Survival Rate
  • Treatment Failure
  • Waiting Lists*

Grants and funding

This study was supported in part by the Spanish Ministry of Economy and Competitiveness (MINECO) (grant ICI14/00016) from the Instituto de Salud Carlos III co-funded by the Fondo Europeo de Desarrollo Regional–FEDER, RETICS (REDINREN RD16/0009/0006, RD16/0009/0031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.